Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
01/2007
01/03/2007CN1890216A Carboxamide derivatives
01/03/2007CN1890215A Inhibitors of hepatitis c virus ns3/ns4a serine protease
01/03/2007CN1890208A Opioid receptor antagonists
01/03/2007CN1889951A Substituted benzazoles and methods of their use as inhibitors of RAF kinase
01/03/2007CN1887883A V-shaped conjugated light-absorbing organic salt compound and its use
01/03/2007CN1293076C Activator for peroxisome proliferator-activated receptor delta
01/03/2007CN1293075C Indole and 2,3-indoline derivative, their preparation and application
01/03/2007CN1293074C Arylindenopyridines with PDE inhibiting activity
01/03/2007CN1293073C Teterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-Hydroxytryptamine-6-ligands
01/03/2007CN1293072C Heterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
01/03/2007CN1293058C O-cyclopropyl-carboxanilides and their use as fungicides
01/03/2007CN1293057C Ethylenediamine derivatives
01/03/2007CN1293056C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
01/03/2007CN1293053C 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
01/03/2007CN1292798C Ethylenedicysteine (EC)-drug conjugates
01/02/2007US7157596 Inhibitors of serine protease activity of matriptase or MTSP1
01/02/2007US7157580 Aminopyrimidine and aminopyridine anti-inflammation agents
01/02/2007US7157489 HIV protease inhibitors
01/02/2007US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection
01/02/2007US7157474 Mixing at least one nonaqueous, pharmaceutically acceptable solvent and a taxane compound
01/02/2007US7157470 For use as anticoagulant agents for therapy of thromboembolic disorders
01/02/2007US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
01/02/2007US7157464 Substituted piperazines
01/02/2007US7157456 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer
01/02/2007US7157455 4-Aminopyrimidine-5-one derivatives
01/02/2007US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
01/02/2007CA2344350C 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
01/02/2007CA2177602C N-substituted azabicycloalkane derivatives, their preparation and use
01/02/2007CA2153419C Novel taxoids, preparation thereof and pharmaceutical compositions containing same
12/2006
12/28/2006WO2006138218A1 Biphenyl compounds useful as muscarinic receptor antagonists
12/28/2006WO2006137485A1 Novel nitrogenated heterocyclic compound and salt thereof
12/28/2006WO2006136924A1 Histamine-3 receptor antagonists
12/28/2006WO2006136552A2 Process for the production of intermadiates for the preparation of tricyclic benzimidazoles
12/28/2006WO2006136305A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM
12/28/2006WO2006098918B1 Substituted gamma lactams as therapeutic agents
12/28/2006WO2006060381A3 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library
12/28/2006WO2006058648A3 Biaryloxymethylarene carboxylic acids
12/28/2006US20060293500 Thiophene-containing compound and polymer thereof
12/28/2006US20060293379 chemoattractant cytokine receptor 2 (CCR2) antagonists such as {4-[(3-bromo-8,9-dihydro-7H-benzocycloheptene-6-carbonyl)-amino]-benzyl}-cyclohexyl-dimethyl-ammonium iodide, useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases; antiinflammatory agents
12/28/2006US20060293375 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases
12/28/2006US20060293373 Gamma-secretase inhibitors
12/28/2006US20060293360 4-(2-Phenyloxyphenyl)-piperidine or-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
12/28/2006US20060293354 Pyrimidine derivatives and their use as CB2 modulators
12/28/2006US20060293353 Matrix metalloproteinase inhibitors
12/28/2006US20060293343 Pyrimidine derivatives
12/28/2006US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase
12/28/2006US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists
12/28/2006US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/28/2006US20060293314 4- Piridinylmethylsulphonamide derivatives as fungicidal plant protein agents
12/28/2006US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
12/28/2006US20060293300 New substituted thiophene carboxamides, process for their preparation and their use as medicaments
12/28/2006US20060293299 3-((1S)-1-{1-[(S)-(3-cyanophenyl)(4-cyanophenyl)methyl]azetidin-3-yl}-2-fluoro-2-methylpropyl)-5-fluorobenzonitrile and its salts; antagonists and inverse agonists of the Cannabinoid-1 receptor
12/28/2006CA2612112A1 Process for the production of intermediates for the preparation of tricyclic benzimidazoles
12/28/2006CA2610326A1 Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kv1.5 potassium channel blockers and pharmaceutical preparations comprising them
12/27/2006EP1736474A1 Piperidine derivative
12/27/2006EP1736471A1 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines
12/27/2006EP1736468A2 Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation
12/27/2006EP1735319A1 Inhibitors of histone deacetylase
12/27/2006EP1735307A1 Inhibitors of iap
12/27/2006EP1735302A1 4-amino-piperidine derivatives as monoamine uptake inhibitors
12/27/2006EP1735301A1 Pyridine derivatives as cannabinoid receptor modulators
12/27/2006EP1735287A1 Therapeutic agents
12/27/2006EP1735286A1 Tetrahydro-indazole cannabinoid modulators
12/27/2006EP1734951A2 Diphenyl-indol-2-on compounds and their use in the treatment of cancer
12/27/2006EP1471786B1 Microbiocidal n-phenyl-n- 4-(4-pyridyl)-2-pyrimidin-2-yl|-amine derivatives
12/27/2006EP1299374B1 Novel non-psychotropic cannabinoids
12/27/2006EP1187826B1 Heterocyclic derivatives useful as anticancer agents
12/27/2006EP1021410B1 Prostaglandin agonists and their use to treat bone disorders
12/27/2006CN1887033A Charge-transporting organic material containing compound having 1,4-dithiin ring
12/27/2006CN1886402A pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists
12/27/2006CN1886399A 喹唑啉衍生物 Quinazoline derivatives
12/27/2006CN1886397A 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3)
12/27/2006CN1886391A Tetronic and tetramic acids as inhibitors of beta-secrease
12/27/2006CN1886381A Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides
12/27/2006CN1886378A 1,4-disubstituted isoquinilone derivatives as RAF-kinase inhibitors useful for the treatment of proliferative diseases
12/27/2006CN1884266A Aromatic-cyclo and heterocyclo acylmethyl imidazole salts compound and method for preparing same
12/27/2006CN1291983C Luminescent element material and luminescent element comprising the same
12/27/2006CN1291720C Non-sedating barbituric acid derivatives
12/26/2006US7153968 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease, eosinophilic granuloma, psoriasis and other benign or malignant proliferative skin diseases, endotoxic shock, laminitis in horses, colic in horses, septic shock, ulcerative colitis, Crohn's disease, reperfusion injury
12/26/2006US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis
12/26/2006US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics
12/26/2006US7153884 C-2′ methylated derivatives of paclitaxel for use as antitumour agents
12/26/2006US7153883 Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
12/26/2006US7153868 N-(3-(4-substituted-1-piperidinyl)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists
12/26/2006US7153857 antiinflammatory agents; antiarthritic agents; anticancer agents
12/26/2006US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer
12/26/2006US7153848 13-C5-7-cycloalkylindolo[2.1-a][2]benzazepine derivatives; e.g., 3-[3-[3-[1-[[(13-cyclohexyl-7H-indolo[2,1-a][2]benzazepin-10-yl)carbonyl]amino]cyclopentyl]-1,2,4-oxadiazol-5-yl]phenyl]-(2E)-2-propenoic acid
12/21/2006WO2006135828A2 Trisubstituted amines as phosphodiesterase 4 inhibitors
12/21/2006WO2006135826A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/21/2006WO2006135705A1 Process for producing cyano substituted arene boranes and compounds
12/21/2006WO2006134989A1 Nitrogenated heterocyclic compound
12/21/2006WO2006134481A1 Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1
12/21/2006WO2006134460A1 Chromane substituted benzimidazole derivatives as acid pump antagonists
12/21/2006WO2006134163A2 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
12/21/2006WO2006133926A1 Pyrazole derivates as cannabinoid receptor modulators
12/21/2006WO2006133821A1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5
12/21/2006WO2006083673A3 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases
12/21/2006WO2005047244A3 Inhibition of fgfr3 and treatment of multiple myeloma
12/21/2006WO2005032468A3 Monocyclic and bicyclic lactams as factor xa inhibitors
12/21/2006US20060287536 Phenyl-thiophene type vitamin d receptor modulators